日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A phase I trial of LXS196, a protein kinase C (PKC) inhibitor, for metastatic uveal melanoma

LXS196(一种蛋白激酶C (PKC) 抑制剂)治疗转移性葡萄膜黑色素瘤的I期临床试验

Piperno-Neumann, S; Carlino, M S; Boni, V; Loirat, D; Speetjens, F M; Park, J J; Calvo, E; Carvajal, R D; Nyakas, M; Gonzalez-Maffe, J; Zhu, X; Shirley, M D; Ramkumar, T; Fessehatsion, A; Burks, H E; Yerramilli-Rao, P; Kapiteijn, E

Regulation of triple-negative breast cancer cell metastasis by the tumor-suppressor liver kinase B1.

肿瘤抑制因子肝激酶B1对三阴性乳腺癌细胞转移的调控

Rhodes L V, Tate C R, Hoang V T, Burks H E, Gilliam D, Martin E C, Elliott S, Miller D B, Buechlein A, Rusch D, Tang H, Nephew K P, Burow M E, Collins-Burow B M